Last reviewed · How we verify

NCT05842759

Avoiding Postinduction Hypotension: the Clinical ZERO-HYPOTENSION Proof-of-concept Study

Completed NA Last updated 11 September 2023
What this trial tests

NA trial testing Monitoring in Hypotension in 120 participants. Completed in 7 August 2023.

Timeline
7 March 2023
Primary endpoint
7 August 2023
7 August 2023

Quick facts

Lead sponsorUniversitätsklinikum Hamburg-Eppendorf
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment120
Start date7 March 2023
Primary completion7 August 2023
Estimated completion7 August 2023
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Universitätsklinikum Hamburg-Eppendorf — full company profile →

Who can join

Adults 45 to 130, any sex, with Hypotension or Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this clinical proof-of-concept study, the aim is to investigate the efficacy of a hypotension avoidance strategy to prevent post-induction hypotension. Specifically, it will be investigate how much postinduction hypotension occurs when using a hypotension avoidance strategy - combining continuous intraarterial blood pressure monitoring, careful administration of anesthetic drugs, and continuous administration of norepinephrine to treat hypotension - in high-risk patients having elective non-cardiac surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A bundle to prevent postinduction hypotension in high-risk noncardiac surgery patients: the ZERO-HYPOTENSION single-arm interventional proof-of-concept study.
    Thomsen KK, Kröker A, Krause L, Kouz K, et al · · 2025 · cited 6× · PMID 40276620 · DOI 10.1016/j.bjao.2025.100392

Verify or expand the search:

Other trials of Monitoring

Trials testing the same drug.

Other recruiting trials for Hypotension

Currently open trials in the same condition.

Other Universitätsklinikum Hamburg-Eppendorf trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05842759.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing